Nuclear Medicine/Radiopharmaceuticals Market: Overview
The increasing prevalence of Cancer, failure of Cardiac, Alzheimer’s, and Parkinson’s are some of the important factor propelling the growth of the global market for nuclear medicine and radiopharmaceuticals market in near future. Rising demand from the growing economies is expected to influence the demand of this market during the course of the forecast period from 2015 to 2023. Furthermore, increasing demand for proper healthcare infrastructure, the non-invasive nature of the process and increasing investment on healthcare in this growing countries is likely to upsurge the demand of this market, positively. The nuclear medicine and radiopharmaceuticals market is further driven by spreading awareness at global level, major progress in development of the radiotracers and the new pipeline of radioisotopes.
On the other hand, very short term life of the radiopharmaceuticals, unavailability of the reimbursement policy and strict policy and rule are some of the factor hampering the growth of the market at global level. The radiation exposure side effects is also one of the important factor driving the demand negatively. The major side effects of the radiation are infertility among men, skin irritation, vomiting, fatigue and nausea.
The global market for nuclear medicine and radiopharmaceuticals can be classified on the basis of the product types and applications. Among all segment, cardiology of the application segments dominates the market in terms of largest market share. Whereas, SPECT of the product types segments expected to account for major share of the market in nuclear medicine and radiopharmaceuticals market in coming years.
Nuclear Medicine/Radiopharmaceuticals Market: Trends
The dependency and importance of the diagnosing disease is one of the major factor significantly driving the demand of the nuclear medicine and radiopharmaceuticals market. The radiopharmaceuticals also helps in diagnosis the heart rate, the mechanism process of kidney cells. The radiopharmaceuticals helps in diagnosing metal health of the patients and it also helps in diagnosing the exact location of bone fracture and the cancers location.
Nuclear Medicine/Radiopharmaceuticals Market: Geography
On the basis of geography, North America is likely to dominate the global market for nuclear medicine and radiopharmaceuticals in terms of usage. The effectiveness of the diagnosis procedure for the early detection of the disease like cancer, cardiac disease is important factor influencing the growth of this market in near future. In 2014, market is dominated by the North America and which is further followed by Europe and Asia Pacific. Furthermore, North America likely to remain dominant due to its increased better infrastructure facility in the healthcare sector, increasing cases of the cancers and cardiac , the increasing advantages that the radiopharmaceuticals have to provide and easy access to radiopharmaceuticals.
Nuclear Medicine/Radiopharmaceuticals Market: Competition
This section of the report highlights the major players operating in the global nuclear medicine and radiopharmaceuticals market. The report also includes some of the leading manufacturers operating in this market such as Sigma Aldrich Corporation, Cardinal Health, Inc., IBA Molecular Imaging, Monrol Nuclear Products and Mallinckrodt Plc.
The study also presents comprehensive analysis of the competitive landscape and key opportunities it could provide during the forecast period from 2015 to 2023
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.